Intestinal microorganisms may produce indole/indole-3-propionic acid, which, when activated by PXR, downregulates the TLR4-NF-B inflammatory pathway in mice
At Real Peptides, our commitment begins with small-batch synthesis to guarantee the exact amino-acid sequencing and purity of every peptide we produce, from foundational compounds like BPC-157 to cutting-edge molecules
In this way, GLP-1 drugs can serve as a catalyst for transformation, empowering you to address root causes and embrace a whole-body approach to vitality
Easy process, relaxing and fun
Researchers tracking peptide clinical trial news should note these ongoing studies: NAFLD/NASH Research The most significant ongoing research involves tesamorelin NAFLD (nonalcoholic fatty liver disease) studies: Rationale: Tesamorelin's documented reduction of visceral adipose tissue may benefit hepatic fat accumulation Key studies: Multiple trials have evaluated tesamorelin's effects on liver fat content in HIV and non-HIV populations Published findings (2024-2025): Studies in JAMA Internal Medicine and Hepatology have documented reductions in hepatic fat fraction Latest tesamorelin research 2025-2026: Recent studies from 2024-2026 continue to evaluate hepatic fat reduction in non-HIV NAFLD/MASH populations, with new analyses examining long-term durability of VAT reduction Cognitive Function Studies Research has explored tesamorelin's effects on cognitive function, particularly in HIV patients where cognitive impairment is common: GH/IGF-1 axis involvement in neuroprotection Studies examining memory and executive function outcomes Ongoing investigation of mechanisms beyond metabolic effects Body Composition Research As a tesamorelin growth hormone analog, research continues into body composition effects: Trunk fat reduction Lipid profile improvements Metabolic marker changes ClinicalTrials.gov Listings Researchers can search ClinicalTrials.gov for "tesamorelin" to find current and completed studies
If youve struggled with weight loss or blood glucose control, youve likely heard about GLP-1 medicationsa breakthrough in both diabetes management and weight loss
